Edition:
United States

Vascular Biogenics Ltd (VBLT.OQ)

VBLT.OQ on NASDAQ Stock Exchange Global Market

1.60USD
20 Sep 2018
Change (% chg)

$-0.03 (-1.54%)
Prev Close
$1.62
Open
$1.60
Day's High
$1.62
Day's Low
$1.60
Volume
462
Avg. Vol
17,095
52-wk High
$9.05
52-wk Low
$1.55

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.18 -0.134
Mar '18 0.16 -0.240
FY 2017 Dec '17 13.86 0.221
Sep '17 0.00 -0.241
Jun '17 0.00 -0.180
Mar '17 0.00 -0.187
FY 2016 Dec '16 0.00 -0.179
Sep '16 0.00 -0.119
Jun '16 0.00 -0.139
Mar '16 0.00 -0.210
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 0.30 0.30 0.30 0.00
Quarter Ending Dec-18 1 0.30 0.30 0.30 0.00
Year Ending Dec-18 1 0.90 0.90 0.90 3.40
Year Ending Dec-19 1 1.00 1.00 1.00 37.17
Earnings (per share)
Quarter Ending Sep-18 1 -0.12 -0.12 -0.12 -0.20
Quarter Ending Dec-18 1 -0.12 -0.12 -0.12 -0.22
Year Ending Dec-18 1 -0.62 -0.62 -0.62 -0.77
Year Ending Dec-19 1 -0.75 -0.75 -0.75 -0.21
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 107.68 32.65
P/E High - Last 5 Yrs. -- 279.69 47.28
P/E Low - Last 5 Yrs. -- 98.16 24.79
Beta -1.86 0.62 0.87
Price to Sales (TTM) 4.10 108.66 6.44
Price to Book (MRQ) 0.80 12.37 3.90
Price to Tangible Book (MRQ) 0.95 18.63 5.95
Price to Cash Flow (TTM) -- 61.73 23.45
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.70
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.63 -5.68
Payout Ratio(TTM) -- 5.94 46.50

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 176.86 8.40
Sales (TTM) vs TTM 1 Yr. Ago -- 93.42 6.69
Sales - 5 Yr. Growth Rate -- 24.48 7.57
EPS (MRQ) vs Qtr. 1 Yr. Ago 25.45 282.99 25.61
EPS (TTM) vs TTM 1 Yr. Ago 40.55 -- --
EPS - 5 Yr. Growth Rate -- 23.63 7.61
Capital Spending - 5 Yr. Growth Rate 111.00 38.58 8.40

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.62 2.20
Current Ratio (MRQ) 10.44 5.44 2.97
LT Debt to Equity (MRQ) 1.05 15.00 11.19
Total Debt to Equity (MRQ) 1.62 18.46 14.01
Interest Coverage (TTM) -- -201.28 35.20

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 96.59 56.05 54.65
Gross Margin - 5 Yr. Avg. -- 52.69 53.29
EBITD Margin (TTM) -78.46 -- --
EBITD - 5 Yr. Avg -518.08 -175.26 15.94
Operating Margin (TTM) -82.67 -602.86 3.76
Operating Margin - 5 Yr. Avg. -523.22 -188.80 11.06
Pre-Tax Margin (TTM) -80.70 -599.74 4.08
Pre-Tax Margin - 5 Yr. Avg. -546.78 -191.11 11.25
Net Profit Margin (TTM) -80.70 -594.93 0.80
Net Profit Margin - 5 Yr. Avg. -546.78 -188.77 7.58
Effective Tax Rate (TTM) -- 11.62 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.25 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) 383,973 5,194,301 714,438,801
Net Income/Employee (TTM) -309,865 -5,791,431 82,488,037
Receivable Turnover (TTM) -- 5.37 5.03
Inventory Turnover (TTM) -- 2.07 3.60
Asset Turnover (TTM) 0.26 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -20.71 0.82 9.74
Return on Assets - 5 Yr. Avg. -42.84 2.59 10.91
Return on Investment (TTM) -23.14 1.61 12.72
Return on Investment - 5 Yr. Avg. -48.65 2.07 14.03
Return on Equity (TTM) -23.85 0.32 14.84
Return on Equity - 5 Yr. Avg. -61.53 -2.31 15.38
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 42.26 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Vascular Biogenics Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 37.46%
# of Holders: 38
Total Shares Held: 13,429,996
3 Mo. Net Change: 5,330,212
# New Positions: 7
# Closed Positions: 10
# Increased Positions: 12
# Reduced Positions: 19
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.